Related Experiment Video
Updated: Jun 18, 2026
02:37
Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma
Published on: December 15, 2023
Developing, regulating, and ethically evaluating new technologies in otolaryngology-head and neck surgery.
Richard R Orlandi1, Bradley F Marple
1Division of Otolaryngology-Head and Neck Surgery, University of Utah, 50 North Medical Drive, 3C120, Salt Lake City, UT 84132, USA. richard.orlandi@hsc.utah.edu
Otolaryngologic Clinics of North America
|November 14, 2009
Summary
Developing new medical technologies in otolaryngology requires overcoming financial and regulatory hurdles. Physicians must ethically manage conflicts of interest and lead the evaluation of new devices after U.S. Food and Drug Administration (FDA) approval.
Area of Science:
- Otolaryngology-head and neck surgery
- Medical device development
- Health technology innovation
Background:
- Technological advancements are transforming otolaryngology-head and neck surgery practices.
- Significant financial and regulatory barriers impede the translation of new medical ideas into clinical practice.
- Physician involvement in technology development creates potential conflicts of interest.
Purpose of the Study:
- To highlight the challenges in developing and implementing new medical technologies in otolaryngology.
- To emphasize the importance of ethical considerations and physician leadership in medical innovation.
- To discuss the role of regulatory bodies like the U.S. Food and Drug Administration (FDA) in device approval.
Main Methods:
- Review of the current landscape of medical technology development in otolaryngology.
- Analysis of financial, regulatory, and ethical factors influencing device implementation.
- Discussion of the physician's role in the technology lifecycle.
Main Results:
- U.S. Food and Drug Administration (FDA) approval primarily assesses device safety, not efficacy.
- Efficacy is often determined by the medical community post-approval.
- Effective management of physician conflicts of interest is crucial.
Conclusions:
- Physicians must ethically lead the development and evaluation of new medical technologies.
- Overcoming barriers is essential for successful translation of innovations.
- A balanced approach to safety and efficacy assessment is needed.
